Drug policies have traditionally sought to suppress supply and deter use through the application of punitive laws. Today, there is a growing recognition that these drug policies have not only failed to reach their objectives but have resulted in a great deal of collateral damage. Drug policy must be reformed to focus on health, human rights and development objectives, with the aim of making the market less harmful rather than necessarily reducing its size.
IDPC explains how civil society has been excluded from the newly-created ‘topical meetings' on the WHO cannabis re-scheduling recommendations, and why this departs from recent progress on openness and civil society participation.
Chang et al. call for an end to the criminalisation of drug use and the enactment of a new reality based on solidarity and cooperation, to protect the health and restore of the rights and dignity of people who use drugs.